Shanghai Bao Pharmaceuticals Co., Ltd.

Shanghai Bao Pharmaceuticals Co., Ltd. is a biotechnology company focused on the research, development, and commercialization of pharmaceutical products in Mainland China. It uses synthetic biology to develop recombinant biologic drugs. Its pipeline includes KJ017, KJ103, SJ02, KJ101, KJ015, BJ007, BJ009, and SJ04, which are in Phase 1 or Phase 2 clinical trials, as well as BJ045, BJ047, BJ008, and BJ044, which are in preclinical stages. The company also licenses intellectual property and provides technical services. Founded in 2019, it is based in Shanghai, China.